Journal
CURRENT OPINION IN NEUROLOGY
Volume 27, Issue 3, Pages 271-278Publisher
LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1097/WCO.0000000000000094
Keywords
axons; multiple sclerosis; myelin; neurons
Categories
Funding
- NMSS [RG-4280]
- NIH [NS38667]
- DOD [W81XWH1210392]
- U.S. Department of Defense (DOD) [W81XWH1210392] Funding Source: U.S. Department of Defense (DOD)
Ask authors/readers for more resources
Purpose of reviewThe predominant clinical disease course of multiple sclerosis starts with reversible episodes of neurological disability, which transforms into progressive neurological decline. This review provides insight into the pathological differences during relapsing and progressive phases of multiple sclerosis.Recent findingsThe clinical course of multiple sclerosis is variable, and the disease can be classified into relapsing and progressive phases. Pathological studies have been successful in distinguishing between these two forms of the disease and correlate with the clinical findings in terms of cellular responses, the inflammatory environment, and the location of lesions.SummaryAvailable therapies for multiple sclerosis patients, while effective during the relapsing phase, have little benefit for progressive multiple sclerosis patients. Development of therapies to benefit progressive multiple sclerosis patients will require a better understanding of the pathogenesis of progressive multiple sclerosis. This review discusses and compares the pathological findings in relapsing and progressive multiple sclerosis patients.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available